NCT05268120View on ClinicalTrials.gov

MRSA Decolonization in Complicated Carriage

NARecruitingINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

July 25, 2022

Primary Completion Date

May 1, 2028

Study Completion Date

May 1, 2028

Conditions
MRSA
Interventions
DRUG

doxycycline 200 mg q.d. - rifampicin 600mg b.i.d.

Both first choice treatments in Dutch guideline for MRSA decolonization

DRUG

trimethoprim 200mg b.i.d. - rifampicin 600mg b.i.d.

Both first choice treatments in Dutch guideline for MRSA decolonization

Trial Locations (1)

Unknown

RECRUITING

LUMC, Leiden

All Listed Sponsors
lead

Leiden University Medical Center

OTHER